Innovative CAR-T Cell Treatment Protocol for Glioblastoma

Exploring a study on unique CAR-T cell therapy for recurrent glioblastoma, targeting specific oncogenic variants and utilizing a bioactive agent for broader tumor microenvironment destruction. Detailed discussion on enrollment criteria, surgical procedures, and rationale behind intraventricular administration.